Your browser doesn't support javascript.
loading
Treating Chronic Prostatitis/Chronic Pelvic Cavity Pain Syndrome with4Dose Regimens:Cost-Effec?tiveness Analysis / 中国药房
China Pharmacy ; (12)1991.
Artigo em Chinês | WPRIM | ID: wpr-527033
ABSTRACT

OBJECTIVE:

To study the cost-effectiveness of4dose regimens in treating chronic prostatitis/chronic pelvic cavity pain syndrome(CP/CPPS).

METHODS:

A total of140patients with CP/CPPS were randomly divided into4groupsBaiyanjing tablets and tamsulosin hydrochloride modified release capsules were administered for Group A;minocycline micro pills and alfuzosin retard tablets for Group B;rexithromycin tablets and doxazosin mesylate controlled release tablets for Group C;and levofloxacin tablets and terazosin tablets for Group D.The cost-effectiveness analysis was performed using pharma?coeconomics.

RESULTS:

The costs for the Group A,B,C and D were268.8yuan,641.8yuan,660.8yuan and666.4yuan,respectively.The effective rates were71.4%,91.4%,88.6%and91.4%,respectively.The cost-effectiveness ratios were3.76,7.02,7.46and7.29,respectively.The incremental cost-effectiveness ratios of Group B,C and D were18.65,22.79and19.88,respectively as against Group A.

CONCLUSION:

The treatment cost of CP/CPPS was composed of2partsan?tibiotics? 1 -receptor blockers.Doctors should make an optimum choice based on patients'previous medication,economic status and physical condition,etc.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Avaliação Econômica em Saúde Idioma: Chinês Revista: China Pharmacy Ano de publicação: 1991 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Avaliação Econômica em Saúde Idioma: Chinês Revista: China Pharmacy Ano de publicação: 1991 Tipo de documento: Artigo